AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsSign up free
🇿🇦

Erlotinib Hydrochloride in South Africa

9 products registered with SAHPRA — 8 active

Brand / ProductReg. No.HolderStatusExpires
TYREC 10055/26/0661Juno Pharma SA (Pty) Ltdactive24 Jan 2028
TYREC 15055/26/0662KAHMA BIOTECH (Pty) Ltdactive24 Jan 2028
TYREC 2555/26/0660Juno Pharma SA (Pty) Ltdactive24 Jan 2028
ERLOTINIB CIPLA 2554/26/0621Cipla Medpro (Pty) Ltdsuspended20 May 2025
ERLOCIP 2554/26/0624.621Cipla Medpro (Pty) Ltdactive1 Jan 1900
ERLOCIP 10054/26/0625.622Cipla Medpro (Pty) Ltdactive1 Jan 1900
ERLOCIP 15054/26/0626.623Cipla Medpro (Pty) Ltdactive1 Jan 1900
ERLOTINIB CIPLA 15054/26/0623Cipla Medpro (Pty) Ltdactive1 Jan 1900
ERLOTINIB CIPLA 10054/26/0622Cipla Medpro (Pty) Ltdactive1 Jan 1900

Erlotinib Hydrochloride — SAHPRA Registration Details

SAHPRA (South Africa) has 9 registered products containing Erlotinib Hydrochloride, of which 8 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.

Track Erlotinib Hydrochloride registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.